rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Granules India Ltd.

532482 GRANULES Group (A)

22 Jul,14:20
516.70
13.70 (2.72%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Granules India Ltd.

BUYSELL
37,664 503.00 517.25 - 494.60 530.40 - 287.55 12,524.81
NSE | BSE

Granules India Ltd.

GRANULES

22 Jul,14:20
516.25
13.25 (2.63%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Granules India Ltd.

BUYSELL
592,357 503.0 517.60 - 495.00 530.65 - 287.70 3,034.82

News for Granules India Ltd.

India-UAE Trade...
India-UAE Trade Pact: GTRI Raises Concerns Over Precious Metal Imports
GTRI expresses concerns about increased precious metal imports from UAE under the India-UAE CEPA, highlighting potential revenue loss and impact on domestic jewellery industry.
Jul 16, 2024 14:58
Lupin Sells...
Lupin Sells Women's Health Business to Evofem for $84 Million
Lupin has divested its US-based women's health speciality business to Evofem Biosciences for up to $84 million. The deal includes the commercialization of Solosec, an FDA-approved treatment for...
Jul 15, 2024 19:54
Granules India Promoter Sells 3.09% Stake for Rs 304 Crore
Krishna Prasad Chigurupati, promoter of Granules India, sold 3.09% stake for Rs 304 crore via open market transaction, reducing his holding to 31.69%.
May 22, 2024 19:13
Granules India Q4 Profit Up 8% to Rs 130 Cr
Granules India's Q4 profit rose 8% to Rs 130 crore, while revenue declined. The company's full-year profit was down 22%. Read more about the financial results and future outlook.
May 15, 2024 17:00
Granules India Gets USFDA Approval for Generic Gout Medication
Granules India receives USFDA approval to market Colchicine Capsules (0.6 mg) for gout prevention and treatment. The generic medication is therapeutically equivalent to Hikma International...
Apr 30, 2024 11:31

More News for Granules India Ltd. »

(Rs. Crore)

Financial Results of Granules India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,755.093,931.203,238.443,134.982,309.93
Operating profit801.36838.24644.65861.37494.14
Interest72.0038.6716.3523.7726.86
Gross profit735.14809.50645.81851.32493.73
EPS (Rs)17.9920.6115.5822.3217.47

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Granules India Ltd.

Granules India Limited is an Indian multinational pharmaceutical manufacturing company based in Hyderabad. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited also operates in the contract research and manufacturing (CRAM) segment. Wikipedia

News for Pharmaceuticals and health care

Clean Coal...
Clean Coal Initiatives: Eco Survey Urges Promotion
India's Economic Survey emphasizes promoting cleaner coal technologies like gasification and coal-to-hydrogen to reduce emissions and achieve energy security.
Jul 22, 2024 14:20
Real Estate...
Real Estate Outlook Encouraging: Economic Survey
India's Economic Survey forecasts a positive outlook for the real estate sector driven by urbanization and rising housing demand, but highlights stalled projects as a challenge.
Jul 22, 2024 14:19
Green Steel: Key...
Green Steel: Key to Low Carbon Economy - Economic Survey
India's Economic Survey highlights the crucial role of green steel in the global shift to a low-carbon economy. Explore the challenges and opportunities for India's steel sector.
Jul 22, 2024 14:16
India Tourism Job...
India Tourism Job Creation: Economic Survey Highlights Potential
India's tourism sector presents a prime opportunity for job creation, says the Economic Survey, citing growth in tourist arrivals and hotel supply. The survey emphasizes the need for skilled...
Jul 22, 2024 14:03
Farm Policy...
Farm Policy Re-orientation: CEA Nageswaran's Call
CEA Nageswaran advocates for a pan-India dialogue on agriculture, urging policy re-orientation despite subsidies, to address challenges like soil degradation and environmental pollution.
Jul 22, 2024 13:56

More News »

Top News

India: GCC Hub for Global Cos - Economic Survey
India emerges as a global favorite for Global Capability Centers (GCCs), with the government playing a crucial role in facilitating their entry. The Economic Survey highlights the country's talent...
Jul 22, 2024 14:22
Clean Coal...
Clean Coal Initiatives: Eco Survey Urges Promotion
India's Economic Survey emphasizes promoting cleaner coal technologies like gasification and coal-to-hydrogen to reduce emissions and achieve energy security.
Jul 22, 2024 14:20
Real Estate...
Real Estate Outlook Encouraging: Economic Survey
India's Economic Survey forecasts a positive outlook for the real estate sector driven by urbanization and rising housing demand, but highlights stalled projects as a challenge.
Jul 22, 2024 14:19
Green Steel: Key...
Green Steel: Key to Low Carbon Economy - Economic Survey
India's Economic Survey highlights the crucial role of green steel in the global shift to a low-carbon economy. Explore the challenges and opportunities for India's steel sector.
Jul 22, 2024 14:16
India Tourism Job...
India Tourism Job Creation: Economic Survey Highlights Potential
India's tourism sector presents a prime opportunity for job creation, says the Economic Survey, citing growth in tourist arrivals and hotel supply. The survey emphasizes the need for skilled...
Jul 22, 2024 14:03

More Top News »

Report Card

PE Ratios
27.97
EPS (Rs.)
17.99
Sales (Rs. Cr)
940.19
Face Value (Rs.)
1
Net Profit Margin (%)
12.68
Last Bonus
Last Dividend(%)
150
Return on Average Equity
18.56

BSE Announcements from Granules India Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 6 day(s) ago
announcement Business Responsibility and Sustainability Reporting (BRSR) - 15 Jul 2024

Compare 'Granules India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Hi, I want to understand about SWP mutual fund...

Hello sir, I am 23 years old, just graduated and...

I was running a bussiness from last seven year with...

Can you please advise SIP in mutual fund. i can take...

I have hdfc small cap, multicap, flexicap funds all...

I have taken early retirement due to my health...

More REDIFFGURUS

RediffGurus

Money question

Dear Sh.Vivek Ji - I am aged 45, unmarried. I am an...

Granules India Ltd. performance snapshot

If you had invested Rs.  in Granules India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Granules India Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Granules India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Granules India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close